Novo Holdings, a leading life science investor, on Monday announced that it has co-led a £90 million ($114 million) Series A financing for Myricx Bio, the largest European biotech Series A financing this year. Myricx Bio is a UK biotech company focusing on the discovery and development of a novel payload class for antibody-drug conjugates […]
Novo Holdings on Monday announced an initial investment in Danish food-tech start-up MATR Foods (‘MATR’) to support the scaling-up of its production of sustainable meat alternatives. Established in Copenhagen in 2021, MATR specialises in developing organic innovative plant-based meat alternatives using traditional fungal fermentation techniques. Locally sourced organic ingredients like oats, split peas, lupins, beetroots, […]
Congratulations to Verona Pharma following the US FDA’s approval of Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Optimum is proud to have worked with the fantastic Verona Pharma team in its journey to getting to this approval for Ohtuvayre, the first inhaled product with a novel mechanism […]
The death cap mushroom is feared throughout much of the world because of the deadly toxin it contains, amanitin. But could the poison reputedly used by Agrippina to murder her husband, the Roman emperor Claudius, be used to destroy cancer, asks Richard Staines. Known to modern science as an inhibitor of RNA polymerase II, alpha-Amanitin […]
STORM Therapeutics Ltd., the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, on Monday announced that Tony Kouzarides, PhD, FMedSci, FRS, its Founder & Director and Professor of Cancer Biology, University of Cambridge, will be honoured with a Knighthood for his global impact on disease treatment. Professor Kouzarides, a world leading […]
